MedPath

PCT of Pharmacopuncture for Chronic Neck Pain

Not Applicable
Recruiting
Conditions
Chronic Pain
Neck Pain
Interventions
Procedure: Pharmacopuncture
Procedure: Acupuncture
Registration Number
NCT06520462
Lead Sponsor
Jaseng Medical Foundation
Brief Summary

A pragmatic clinical study to compare the effectiveness of pharmacopuncture and acupuncture treatment strategies in patients with chronic neck pain

Detailed Description

This study aims to confirm the comparative effectiveness of pharmacopuncture by conducting a pragmatic randomized controlled clinical trial with 128 patients suffering from chronic neck pain. The trial will compare patients treated with a pharmacopuncture-based strategy (64 patients) to those treated with an acupuncture-based strategy (64 patients). As this is a pragmatic clinical trial, participants will be randomly assigned to either the pharmacopuncture or acupuncture groups. However, the specific methods of pharmacopuncture and acupuncture to be used will not be predetermined. Instead, they will be determined based on the clinical judgment of the traditional Korean medicine doctor according to the patient's condition. All methods used will be recorded in the CRF (Case Report Form).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
128
Inclusion Criteria
  1. Patients with neck pain persisting for more than 3 months
  2. Patients with a Numeric Rating Scale (NRS) score of 5 or higher for neck pain
  3. Patients aged between 19 and 70 years
  4. Patients who agree to participate in the clinical study and provide a written informed consent form
Exclusion Criteria
  1. Patients diagnosed with serious specific diseases that could be the cause of neck pain (e.g., spinal metastasis of tumors, acute fractures, and spinal dislocations)
  2. Patients exhibiting progressive neurological deficits or severe neurological symptoms
  3. Patients whose pain originates from soft tissue disorders rather than the spine (e.g., tumors, fibromyalgia, rheumatoid arthritis, gout)
  4. Patients with other chronic diseases that could interfere with the interpretation of treatment effects or outcomes (e.g., stroke, myocardial infarction, kidney disease, diabetic neuropathy, dementia, epilepsy)
  5. Patients currently taking steroids, immunosuppressants, psychiatric medications, or other drugs that could affect the study results
  6. Patients for whom pharmacopuncture treatment is inappropriate or unsafe: those with bleeding disorders, those undergoing anticoagulant therapy, and severe diabetic patients with infection risks
  7. Patients who have taken medications that could affect pain (e.g., Non-Steroidal Anti-Inflammatory Drugs, NSAIDs) or received pharmacopuncture, acupuncture, or physical therapy within the past week
  8. Pregnant women, those planning to become pregnant, or those currently breastfeeding
  9. Patients who have undergone cervical spine surgery within the past 3 months
  10. Patients who have not completed participation in another clinical study within the past month or plan to participate in another clinical study during the study participation and follow-up period within 6 months from the date of selection
  11. Patients who find it difficult to provide informed consent for participation
  12. Other cases where the researcher deems participation in the clinical study to be difficult

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Pharmacopuncture groupPharmacopuncture1. Acupoints: The selection of acupoints, depth of insertion, and other procedural details are determined based on the clinical judgment of the physicians according to the participant's symptoms, diagnostic imaging, and degree of improvement. Acupoints may include GB20, GB21, BL11, and EX-B2. However, these acupoints are not restrictive; any acupoints used for the treatment of chronic neck pain will be documented. 2. Pharmacopuncture: The type and dosage of the pharmacopuncture solution used during treatment will be selected based on the clinical judgment of the physicians performing the pharmacopuncture. The types of pharmacopuncture solutions and the total amount administered will be recorded. The choice will be based on the participant's symptoms and the clinical judgment within the range of pharmacopuncture solutions currently used in clinical practice at the trial institution, without adding new solutions specifically for this study.
Acupuncture groupAcupunctureThe selection of acupoints, depth of insertion, and other procedural details are to be determined based on the clinical judgment of the physicians according to the participant's symptoms, diagnostic imaging, and degree of improvement. Acupoints may include sites such as GB21, SI9, GB20, GV14, and distal points like SI3. The number of needles used can range from 5 to 30. All acupoints treated during the procedure are to be documented.
Primary Outcome Measures
NameTimeMethod
Neck pain Numeric Rating Scale, NRSWeek 5

Change from baseline to Week 5 on the Numeric Rating Scale of neck pain

Secondary Outcome Measures
NameTimeMethod
Patient Global Impression of ChangeWeek 5,8,12

The subject's subjective improvement

Northwick Park QuestionnaireWeek 1,5,8,12

A self-reported questionnaire consisting of 9 items related to the impact of neck pain on daily activities

Neck disability indexWeek 1,5,8,12

The degree of neck disability in daily life

Health-related Quality of Life Instrument with 8 ItemsWeek 1,5,8,12

A tool developed to measure the health-related quality of life in Koreans

5-Level EuroQol-5 DimensionWeek 1,5,8,12

A tool that evaluates health status from multiple perspectives, including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.

Neck and arm pain Numeric Rating ScaleWeek 1,2,3,4,5,8,12

The pain intensity of neck and arm over the past week

Neck and arm pain Visual Analogue ScaleWeek 1,2,3,4,5

The pain intensity of neck and arm over the past week

Adverse eventsWeek 1,2,3,4,5,8,12

An undesirable and unintended sign, symptom, or disease that occurs after a procedure during the clinical study.

Trial Locations

Locations (6)

Kyung Hee University Korean Medicine Hospital

🇰🇷

Seoul, Dongdaemun-gu, Korea, Republic of

Kyung Hee University Korean Medicine Hospital at Gangdong

🇰🇷

Seoul, Gangdong-gu, Korea, Republic of

Dongguk University Bundang Oriental Hospital

🇰🇷

Seongnam, GGyeonggi-do, Korea, Republic of

Bucheon Jaseng Hospital of Korean Medicine

🇰🇷

Bucheon, Gyeonggi Province, Korea, Republic of

Haeundae Jaseng Hospital of Korean Medicine

🇰🇷

Busan, Korea, Republic of

Daejeon Jaseng Hospital of Korean Medicine

🇰🇷

Daejeon, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath